Chris@CNW, Author at CannabisNewsWire

ThursdayNov 16, 2023 4:20 pm

420 with CNW — Ohio Vote Means Recreational Cannabis Now Legal in 24 States

Ohio voters gave their approval last week to the legalization of recreational marijuana cultivation and sales, opening the doors to a potentially lucrative market in the Midwest. This milestone was achieved with around 53% of the votes counted, where supporters of Issue 2 were leading with 55.7% in favor against 44.3% opposed. This makes Ohio the 24th state to legalize recreational marijuana following a prolonged and contentious process. It is expected that the new recreational cannabis market could generate revenues close to $2 billion within the first year of operation, ultimately increasing to $4 billion by the fourth year, according…

ThursdayNov 16, 2023 4:20 am

420 with CNW — Lawsuits, Elections Could Impact Cannabis Rescheduling Timeline

With both the White House and Senate in the hands of the Democrats, the chances of federal cannabis legalization becoming a reality have skyrocketed. President Joe Biden based part of his campaign on cannabis reform, and his administration's Department of Health and Human Services (HHS) recently issued a recommendation to the U.S. Drug Enforcement Administration to loosen cannabis restrictions on the federal level. However, even though the current administration is throwing its weight behind cannabis reform and the DEA is likely to abide by HHS’ recommendation, lawsuits and elections may impact the timeline for federal cannabis rescheduling. Many drug reform…

WednesdayNov 15, 2023 4:20 pm

420 with CNW — Report from Illinois Highlights Significant Diversity Improvements in Cannabis Industry

Recent cannabis data from Illinois has revealed a sharp increase in diversity since the state launched recreational cannabis sales in January 2020. The Illinois Cannabis Regulation Oversight Officer (CROO) states that cannabis businesses in the early days of adult-use sales were 100% majority owned with only one majority woman-owned cannabis enterprise in the entire state. However, a survey report published last week shows that efforts to promote diversity in the Illinois recreational cannabis industry have yielded great success. The surveys found that the number of Black-owned businesses in the sector increased from 0 27% from 2020 to 2023. Hispanic or…

WednesdayNov 15, 2023 4:20 am

420 with CNW — Newly Released FDA Documents Shed Light on 50 Years of Cannabis Research

For several decades, the federal government’s categorization of marijuana as a Schedule I controlled substance has prompted the FDA to assess various applications from researchers looking to create therapeutic drugs derived from the plant. The FDA recently published two documents that reflect on more than 50 years of exploring marijuana-based drugs and offer insights into the potential future of drug development. The documents highlight the evolution of the FDA’s evaluations regarding marijuana-related drugs and products and also discuss the exploration of different consumption methods, such as edibles, and delve into the examination of lesser-known cannabinoids and additional components like terpenes.…

TuesdayNov 14, 2023 4:20 pm

420 with CNW — Senate Passes Bill Giving VA Doctors Leeway to Recommend Marijuana Treatments

The U.S. Senate has approved a measure that will allow doctors to recommend medical marijuana treatments to military veterans. Titled the Fiscal Year 2024 (FY24) Military Construction, Veterans Affairs, and Related Agencies (MilCon-VA) Appropriations Act, the bipartisan congressional bill will allow veterans to access medical marijuana as long as they have a government doctor recommendation. Department of Veteran Affairs (VA) doctors will now have the ability to recommend medical cannabis to their patients as long as they reside in states with legal marijuana markets. The measure will provide support for American military forces and their families in critical facets such…

TuesdayNov 14, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes $200 Billion GLP-1 Market with its DehydraTECH(TM) Technology

Lexaria, a global innovator in drug delivery platforms, is exploring the impact of its patented DehydraTECH(TM) technology on the oral performance of GLP-1 drugs for potential diabetes and weight loss treatment The company hopes to make these drugs more effective with reduced side effects, and even more accessible to people living with diabetes The move is aimed to help the company partner with the behemoths in an industry projected to bring in between $150 billion and $200 billion a year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is evaluating the impact of its patented DehydraTECH(TM) technology…

TuesdayNov 14, 2023 4:20 am

420 with CNW — Nevada Approves Six Additional Cannabis Consumption Lounges

Nevada authorities are still granting more licenses for consumption lounges, with the state’s marijuana compliance board (CCB) recently giving the green light to six additional conditional licenses for various marijuana businesses, including TGIG LLC; NevadaPure LLC; Higher* Archy LLC; Desert Evolution LLC; Green Thumb Industries (GTI); and Curaleaf Holdings. Curaleaf Holdings, a global cannabis giant, obtained one license for Tryke Companies, its subsidiary that runs Reef Dispensaries. GTI, another significant player in the multistate marijuana sector, also secured a license for Integral Associates, its subsidiary, with intentions to open a club on the Strip. The CCB stated in June last…

MondayNov 13, 2023 4:20 pm

420 with CNW — Cannabis Firms Uplist Stocks in Canada in Preparation for US Listing

Multiple marijuana multistate operators (MSOs) are elevating their stock listings in Canada to higher-tier exchanges, setting a trend that more are likely to follow. However, their main objective appears to be listing on U.S. exchanges such as the NASDAQ or the New York Stock Exchange (NYSE). The shift involves MSOs moving from the lower Canadian Securities Exchange (CSE) to the Cboe Canada Exchange or the Toronto Stock Exchange (TSX). This transition holds potential advantages, including increased liquidity and trading volume, access to institutional investments, and meeting stricter listing requirements, aligning these companies closer to conditions necessary for listing on the…

MondayNov 13, 2023 4:20 am

420 with CNW — Bipartisan Bill to Legalize Cannabis Federally Is Reintroduced in Congress

A Republican has reintroduced a bipartisan measure that would legalize cannabis at the federal level to Congress. South Carolina Republican Representative Nancy Mace reintroduced the States Reform Act, a measure to amend the federal Controlled Substances Act and allow cannabis at the federal level. The proposal is currently acting as a placeholder and has no text. Even so, it is cosponsored by Republican Representatives Matt Gaetz (Florida) and Tom McClintock (California) as well as Democratic Representatives Dean Phillips (Minnesota) and David Trone (Maryland). Democrats have largely been behind America’s decade-long wave of cannabis reform and are currently working to legalize…

FridayNov 10, 2023 4:20 pm

420 with CNW — Study Shows Opioid Prescription Rates Reduce When Patients Can Legally Access CBD

A recent study investigating the impact of CBD availability on opioid prescriptions has revealed that although legalizing CBD alone does not automatically reduce the rate of opioid prescriptions, making legal CBD products readily available and affordable has significantly reduced the number of opioid prescriptions by approximately 8.1%. The study, which was recently published in the “Journal of Southern Economics,” suggests that three key factors impact the opioid crisis: prescription CBD legalization, regulations that limit CBD purchases and access through CBD dispensaries. To conduct the study, the authors scrutinized state laws concerning restricted-access, CBD-only regulations in states such as Texas, Iowa…